BlackRock Fund Advisors’s Minerva Neurosciences NERV Stock Holding History

BlackRock Fund Advisors’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$12.8M	Buy	136,466 +70,425	+107%	+$7.19M	﹤0.01%	2437
2016 Q3	$7.46M	Buy	66,041 +14,340	+28%	+$1.39M	﹤0.01%	2636
2016 Q2	$4.22M	Buy	51,701 +48,464	+1,497%	+$3.08M	﹤0.01%	2896
2016 Q1	$159K	Buy	3,237 +121	+4%	+$5.17K	﹤0.01%	3548
2015 Q4	$151K	Buy	3,116 +552	+22%	+$23K	﹤0.01%	3628
2015 Q3	$108K	Sell	2,564 -68	-3%	-$3.12K	﹤0.01%	3680
2015 Q2	$122K	Buy	+2,632	New	+$112K	﹤0.01%	3692

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock Fund Advisors's NERV Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Minerva Neurosciences (NERV) stake by 107% in Q4 2016, buying an estimated $7.19M and bringing the position to 136,466 shares worth $12.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2437.

BlackRock Fund Advisors first reported a position in NERV in Q2 2015 and has held it in 7 quarters since. 78 funds tracked by Wall St. Rank hold NERV as of Q4 2016.

BlackRock Fund Advisors held 136,466 shares of Minerva Neurosciences worth $12.8M as of Q4 2016.
BlackRock Fund Advisors bought 70,425 Minerva Neurosciences shares in Q4 2016, an estimated $7.19M.
Minerva Neurosciences made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2437 holding.
BlackRock Fund Advisors first reported a position in Minerva Neurosciences in Q2 2015 and has held it in 7 quarters since.
78 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.